Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

8-MOP plasma levels in PUVA problem cases with psoriasis.

G Wagner, C Hofmann, U Busch

    The British Journal of Dermatology
    |September 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Age-specific patterns of lymph node involvement in elderly patients with oral squamous cell carcinoma: a retrospective cohort study.

    Clinical oral investigations·2026
    Same author

    Diagnosis, treatment and monitoring of chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO) - Evidence, practice and consensus-based recommendations from the German pediatric rheumatology society (GKJR).

    Autoimmunity reviews·2026
    Same author

    Diagnosis and Treatment of Hypophosphatasia.

    Calcified tissue international·2025
    Same author

    At-Home Administration of Gantenerumab by Care Partners to People with Early Alzheimer's Disease: Feasibility, Safety and Pharmacodynamic Impact.

    The journal of prevention of Alzheimer's disease·2024
    Same author

    Thirty-Six-Month Amyloid Positron Emission Tomography Results Show Continued Reduction in Amyloid Burden with Subcutaneous Gantenerumab.

    The journal of prevention of Alzheimer's disease·2020
    Same author

    Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020

    Psoriatic patients with poor response to PUVA therapy had lower 8-methoxypsoralen (8-MOP) plasma levels and delayed absorption compared to those with adequate responses. Optimizing UV-A irradiation timing improved outcomes for some patients.

    Area of Science:

    • Dermatology
    • Pharmacokinetics
    • Photochemotherapy

    Background:

    • Psoriasis is a chronic inflammatory skin condition.
    • Photochemotherapy, specifically PUVA (psoralen plus UVA light), is a common treatment for psoriasis.
    • Variability in patient response to PUVA suggests underlying pharmacokinetic differences.

    Purpose of the Study:

    • To compare 8-methoxypsoralen (8-MOP) plasma pharmacokinetics between psoriatic patients with poor and adequate responses to PUVA treatment.
    • To investigate potential correlations between 8-MOP plasma levels, absorption kinetics, and therapeutic outcomes.
    • To explore if adjusting UV-A irradiation timing based on 8-MOP plasma peaks improves treatment efficacy.

    Main Methods:

    • Oral administration of 8-MOP (0.6-0.8 mg/kg) to psoriatic patients (N=14 poor responders, N=7 adequate responders).

    Related Experiment Videos

  • Measurement of 8-MOP plasma levels over 8 hours using gas chromatography.
  • Analysis of plasma kinetics, including peak levels and time to peak, in relation to treatment response.

    • Main Results:

    • Poor responders exhibited significantly lower 8-MOP plasma levels compared to adequate responders.
    • The rate of 8-MOP plasma increase was slower in poor responders.
    • Fifty percent of poor responders showed deviations in the time to maximum 8-MOP plasma levels, versus 14% of controls.
    • No dose-response correlation was observed for 8-MOP plasma levels.
    • Adjusting UV-A irradiation to 8-MOP plasma peaks improved outcomes in three poor responders.

    Conclusions:

    • Lower and delayed 8-MOP plasma levels may contribute to poor PUVA treatment response in some psoriatic patients.
    • Individualized UV-A irradiation timing, synchronized with 8-MOP plasma peaks, shows potential for improving therapeutic results.
    • Further research into pharmacokinetic variability can optimize photochemotherapy protocols for psoriasis.